K Osmundsen

435 total citations
10 papers, 358 citations indexed

About

K Osmundsen is a scholar working on Epidemiology, Molecular Biology and Pharmacology. According to data from OpenAlex, K Osmundsen has authored 10 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in K Osmundsen's work include Lipid metabolism and disorders (3 papers), Pharmacology and Obesity Treatment (3 papers) and Urinary Tract Infections Management (2 papers). K Osmundsen is often cited by papers focused on Lipid metabolism and disorders (3 papers), Pharmacology and Obesity Treatment (3 papers) and Urinary Tract Infections Management (2 papers). K Osmundsen collaborates with scholars based in United States, Norway and Sweden. K Osmundsen's co-authors include Henry N. Ginsberg, Marian M. Adams, Neil S. Shachter, Sheryl L. Windsor, Lars Berglund, Claus Luley, Matthias Orth, Sabine Westphal, Andreas Ambrosch and F. A. Kummerow and has published in prestigious journals such as American Journal of Clinical Nutrition, Journal of Lipid Research and Atherosclerosis.

In The Last Decade

K Osmundsen

9 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K Osmundsen United States	5	200	147	143	88	86	10	358
Sidika E. Kasim United States	8	131 0.7×	136 0.9×	192 1.3×	38 0.4×	62 0.7×	12	419
T. Olivecrona Sweden	8	151 0.8×	66 0.4×	141 1.0×	41 0.5×	95 1.1×	24	408
K. Grønseth Norway	7	159 0.8×	116 0.8×	39 0.3×	71 0.8×	71 0.8×	10	356
J Válek Czechia	10	151 0.8×	78 0.5×	178 1.2×	33 0.4×	41 0.5×	42	393
Jacques I. Kessler Canada	11	68 0.3×	101 0.7×	124 0.9×	54 0.6×	87 1.0×	19	374
F M Sacks United States	8	119 0.6×	67 0.5×	164 1.1×	36 0.4×	42 0.5×	11	359
Patty W. Siri United States	7	54 0.3×	126 0.9×	211 1.5×	43 0.5×	72 0.8×	7	508
I Puhakainen Finland	9	76 0.4×	85 0.6×	171 1.2×	38 0.4×	30 0.3×	10	485
Junichiro Kinoshita Japan	7	91 0.5×	70 0.5×	232 1.6×	50 0.6×	109 1.3×	8	537
Olivier Scruel France	11	52 0.3×	142 1.0×	141 1.0×	30 0.3×	23 0.3×	20	311

Countries citing papers authored by K Osmundsen

Since Specialization

Citations

This map shows the geographic impact of K Osmundsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Osmundsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Osmundsen more than expected).

Fields of papers citing papers by K Osmundsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Osmundsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Osmundsen. The network helps show where K Osmundsen may publish in the future.

Co-authorship network of co-authors of K Osmundsen

This figure shows the co-authorship network connecting the top 25 collaborators of K Osmundsen. A scholar is included among the top collaborators of K Osmundsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Osmundsen. K Osmundsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Westphal, Sabine, Matthias Orth, Andreas Ambrosch, K Osmundsen, & Claus Luley. (2000). Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n−3 fatty acids. American Journal of Clinical Nutrition. 71(4). 914–920. 61 indexed citations

Aamdal, Steinar, et al.. (1998). Zilascorb(2H), a low-toxicity protein synthesis inhibitor that exhibits signs of anticancer activity in malignant melanoma. Anti-Cancer Drugs. 9(9). 797–802. 1 indexed citations

Osmundsen, K, et al.. (1997). Zilascorb(2H), a new reversible protein synthesis inhibitor: clinical study of an oral preparation. Anti-Cancer Drugs. 8(3). 296–303.

Shachter, Neil S., et al.. (1997). 2.P.38 Long-term effects of low dose Omacor® in patients with severe hypertriglyceridemia. Atherosclerosis. 134(1-2). 124–124. 2 indexed citations

Osmundsen, K, et al.. (1997). Alterations in serum phosphatidylcholine fatty acyl species by eicosapentaenoic and docosahexaenoic ethyl esters in patients with severe hypertriglyceridemia. Journal of Lipid Research. 38(3). 429–436. 13 indexed citations

Ginsberg, Henry N., Neil S. Shachter, Sheryl L. Windsor, et al.. (1997). Safety and Efficacy of Omacor in Severe Hypertriglyceridemia. European Journal of Cardiovascular Prevention & Rehabilitation. 4(5-6). 385–391. 254 indexed citations

Osmundsen, K, et al.. (1986). [Frequent cystitis in elderly women. A double-blind comparison of Hiprex and placebo in general practice].. PubMed. 106(25). 2048–9. 12 indexed citations

Høivik, Hans Olav, et al.. (1986). [Combined analgesics in myalgia of the neck. A double-blind comparison of paracetamol and orphenadrine (Norgesic) and paracetamol and codeine (Paralgin forte) in general practice].. PubMed. 106(2). 126–8. 2 indexed citations

Osmundsen, K, et al.. (1984). [Prevention of recurrent cystitis in fertile women. A double-blind comparison of Hiprex and placebo in general practice].. PubMed. 104(16). 1150–2. 10 indexed citations

10.

Høivik, Hans Olav, et al.. (1983). [Effect of orphenadrine/paracetamol combination tablets (Norgesic) on myalgia. A double-blind comparative study using a placebo in general practice].. PubMed. 103(6). 597–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact